EyePoint, Inc. (EYPT)
4.58
+0.02
(+0.33%)
USD |
NASDAQ |
Sep 04, 16:00
4.575
0.00 (0.00%)
After-Hours: 20:00
EyePoint SG&A Expense (TTM) : 55.41M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 55.41M |
| March 31, 2026 | 53.04M |
| December 31, 2025 | 51.70M |
| September 30, 2025 | 52.96M |
| June 30, 2025 | 51.44M |
| March 31, 2025 | 52.34M |
| December 31, 2024 | 52.54M |
| September 30, 2024 | 51.33M |
| June 30, 2024 | 49.38M |
| March 31, 2024 | 50.92M |
| December 31, 2023 | 51.79M |
| September 30, 2023 | 54.77M |
| June 30, 2023 | 58.96M |
| March 31, 2023 | 60.06M |
| December 31, 2022 | 60.32M |
| September 30, 2022 | 62.94M |
| June 30, 2022 | 61.14M |
| March 31, 2022 | 57.55M |
| December 31, 2021 | 53.08M |
| September 30, 2021 | 47.64M |
| June 30, 2021 | 45.27M |
| March 31, 2021 | 44.31M |
| December 31, 2020 | 46.02M |
| September 30, 2020 | 45.98M |
| June 30, 2020 | 47.06M |
| Date | Value |
|---|---|
| March 31, 2020 | 48.28M |
| December 31, 2019 | 47.71M |
| September 30, 2019 | 45.43M |
| June 30, 2019 | 41.10M |
| March 31, 2019 | 34.73M |
| December 31, 2018 | 25.09M |
| September 30, 2018 | 18.44M |
| June 30, 2018 | 13.06M |
| March 31, 2018 | 10.23M |
| June 30, 2017 | 11.24M |
| March 31, 2017 | 11.27M |
| December 31, 2016 | 11.19M |
| September 30, 2016 | 10.33M |
| June 30, 2016 | 9.013M |
| March 31, 2016 | 8.768M |
| December 31, 2015 | 8.463M |
| September 30, 2015 | 8.29M |
| June 30, 2015 | 8.056M |
| March 31, 2015 | 7.645M |
| December 31, 2014 | 7.55M |
| September 30, 2014 | 7.391M |
| June 30, 2014 | 7.468M |
| March 31, 2014 | 7.621M |
| December 31, 2013 | 7.413M |
| September 30, 2013 | 7.36M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ocular Therapeutix, Inc. | 135.74M |
| Eli Lilly & Co. | 12.24B |
| Elanco Animal Health, Inc. | 1.519B |
| Amylyx Pharmaceuticals, Inc. | 69.66M |
| Nuvation Bio, Inc. | 158.58M |